Clinical Trial

Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal Neuralgia

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Trigeminal neuralgia is a debilitating neurological condition, affecting quality of life in most affected patients. Carbamazepine has traditionally been used for the management of this condition, but it has a moderate effectiveness and a poor side-effect profile. Oxcarbazepine is more tolerable, and has a more favorable side-effect profile. This study aims to compare the effectiveness of oxcarbazepine and carbamazepine in the management of this condition, for improved prescription practices in the future.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-23.
Trial Details
NCT Number NCT06849219
Lead Sponsor Jinnah Postgraduate Medical Centre
Conditions Trigeminal Neuralgia
Enrollment 122 participants
Start Date 2024-09-21
Primary Completion 2025-01-30 (estimated)
Study Completion 2025-03-21 (estimated)
Updated on ClinicalTrials.gov 2025-03-04